Stereotaxis Return on Tangible Equity 2010-2025 | STXS
Current and historical return on tangible equity values for Stereotaxis (STXS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Stereotaxis Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.03B | $0.00B | -600.00% |
| 2024-12-31 | $-0.03B | $0.00B | -253.66% |
| 2024-09-30 | $-0.02B | $0.00B | -146.03% |
| 2024-06-30 | $-0.02B | $0.02B | -106.02% |
| 2024-03-31 | $-0.02B | $0.02B | -90.32% |
| 2023-12-31 | $-0.02B | $0.02B | -86.27% |
| 2023-09-30 | $-0.02B | $0.02B | -75.00% |
| 2023-06-30 | $-0.02B | $0.03B | -66.12% |
| 2023-03-31 | $-0.02B | $0.03B | -61.54% |
| 2022-12-31 | $-0.02B | $0.03B | -51.80% |
| 2022-09-30 | $-0.02B | $0.03B | -49.32% |
| 2022-06-30 | $-0.02B | $0.04B | -47.06% |
| 2022-03-31 | $-0.02B | $0.04B | -37.74% |
| 2021-12-31 | $-0.01B | $0.04B | -32.30% |
| 2021-09-30 | $-0.01B | $0.04B | -27.16% |
| 2021-06-30 | $-0.01B | $0.04B | -19.63% |
| 2021-03-31 | $-0.01B | $0.04B | -19.75% |
| 2020-12-31 | $-0.01B | $0.04B | -21.48% |
| 2020-09-30 | $-0.01B | $0.04B | -20.29% |
| 2020-06-30 | $-0.01B | $0.04B | -15.87% |
| 2020-03-31 | $-0.01B | $0.03B | -22.22% |
| 2019-12-31 | $-0.01B | $0.03B | -29.41% |
| 2019-09-30 | $0.00B | $0.03B | -34.78% |
| 2019-06-30 | $0.00B | $0.01B | -64.00% |
| 2019-03-31 | $0.00B | $0.01B | -42.86% |
| 2018-12-31 | $0.00B | $0.01B | -12.90% |
| 2018-09-30 | $0.00B | $0.01B | -400.00% |
| 2018-06-30 | $-0.01B | $0.01B | 139.13% |
| 2018-03-31 | $-0.01B | $0.01B | 71.11% |
| 2017-12-31 | $-0.01B | $-0.02B | 47.76% |
| 2017-09-30 | $0.00B | $-0.02B | 6.45% |
| 2017-06-30 | $-0.01B | $-0.01B | 48.48% |
| 2017-03-31 | $-0.01B | $-0.01B | 48.65% |
| 2016-12-31 | $-0.01B | $-0.02B | 55.00% |
| 2016-09-30 | $-0.02B | $-0.02B | 87.80% |
| 2016-06-30 | $-0.01B | $-0.02B | 35.90% |
| 2016-03-31 | $-0.01B | $-0.02B | 38.36% |
| 2015-12-31 | $-0.01B | $-0.02B | 46.38% |
| 2015-09-30 | $-0.01B | $-0.02B | 30.77% |
| 2015-06-30 | $0.00B | $-0.02B | 25.81% |
| 2015-03-31 | $0.00B | $-0.02B | 26.23% |
| 2014-12-31 | $-0.01B | $-0.01B | 32.26% |
| 2014-09-30 | $-0.01B | $-0.02B | 65.57% |
| 2014-06-30 | $-0.07B | $-0.02B | 406.06% |
| 2014-03-31 | $-0.07B | $-0.02B | 353.25% |
| 2013-12-31 | $-0.07B | $-0.01B | 324.71% |
| 2013-09-30 | $-0.07B | $-0.02B | 296.77% |
| 2013-06-30 | $-0.01B | $-0.03B | 62.22% |
| 2013-03-31 | $-0.01B | $-0.03B | 40.51% |
| 2012-12-31 | $-0.01B | $-0.02B | 45.00% |
| 2012-09-30 | $-0.01B | $-0.02B | 55.00% |
| 2012-06-30 | $-0.02B | $-0.02B | 81.01% |
| 2012-03-31 | $-0.03B | $-0.03B | 161.11% |
| 2011-12-31 | $-0.03B | $-0.02B | 280.85% |
| 2011-09-30 | $-0.03B | $-0.02B | 644.44% |
| 2011-06-30 | $-0.03B | $-0.01B | 1080.00% |
| 2011-03-31 | $-0.02B | $0.00B | 1680.00% |
| 2010-12-31 | $-0.02B | $0.01B | 1900.00% |
| 2010-09-30 | $-0.02B | $-0.01B | 1600.00% |
| 2010-06-30 | $-0.03B | $0.00B | 714.29% |
| 2010-03-31 | $-0.03B | $0.00B | 509.09% |
| 2009-12-31 | $-0.03B | $0.01B | 400.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.195B | $0.027B |
| Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.550B | 80.39 |
| Thermo Fisher Scientific (TMO) | United States | $147.321B | 17.82 |
| Edwards Lifesciences (EW) | United States | $42.980B | 28.18 |
| IDEXX Laboratories (IDXX) | United States | $41.867B | 48.11 |
| Alcon (ALC) | Switzerland | $41.867B | 28.29 |
| DexCom (DXCM) | United States | $32.086B | 49.59 |
| IQVIA Holdings (IQV) | United States | $26.659B | 14.93 |
| Mettler-Toledo (MTD) | United States | $23.912B | 28.44 |
| STERIS (STE) | Ireland | $23.322B | 25.69 |
| Waters (WAT) | United States | $20.299B | 28.64 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.846B | 0.00 |
| Hologic (HOLX) | United States | $14.293B | 15.53 |
| Sysmex ADR (SSMXY) | Japan | $10.555B | 29.94 |
| Penumbra (PEN) | United States | $9.912B | 77.80 |
| Masimo (MASI) | United States | $8.638B | 31.86 |
| Globus Medical (GMED) | United States | $7.871B | 18.75 |
| Glaukos (GKOS) | United States | $5.703B | 0.00 |
| Teleflex (TFX) | United States | $5.194B | 8.57 |
| TransMedics (TMDX) | United States | $4.607B | 100.15 |
| Integer Holdings (ITGR) | United States | $4.154B | 21.77 |
| PROCEPT BioRobotics (PRCT) | United States | $3.266B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.418B | 14.40 |
| Veracyte (VCYT) | United States | $2.096B | 29.41 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.586B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.337B | 0.00 |
| Artivion (AORT) | United States | $1.271B | 119.08 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.944B | 5.02 |
| Beta Bionics (BBNX) | United States | $0.790B | 0.00 |
| IRadimed (IRMD) | United States | $0.737B | 37.41 |
| SiBone (SIBN) | United States | $0.731B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 8.73 |
| RxSight (RXST) | United States | $0.549B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.510B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.506B | 11.86 |
| OrthoPediatrics (KIDS) | United States | $0.495B | 0.00 |
| AxoGen (AXGN) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.413B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.412B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.390B | 0.00 |
| NeuroPace (NPCE) | United States | $0.354B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.318B | 8.47 |
| ClearPoint Neuro (CLPT) | United States | $0.313B | 0.00 |
| 908 Devices (MASS) | United States | $0.264B | 0.00 |
| Neuronetics (STIM) | United States | $0.230B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.82 |
| Sight Sciences (SGHT) | United States | $0.208B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.152B | 0.00 |
| CVRx (CVRX) | United States | $0.148B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.47 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |